Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Triple receptor agonist (GLP, GLP-1, Glucagon) for metabolic pathway research
Key Features & Research Applications
Triple receptor engagement (GLP + GLP-1 + Glucagon): Enables comprehensive investigation of incretin and glucagon pathways for glucose and energy metabolism in vitro/preclinical models.
Engineered stability: Incorporates structural modifications for extended half-life and albumin binding in research contexts
Lab-friendly format: Supplied lyophilized; recommended storage at –20 °C, protected from light/moisture; solubility references include DMSO for stock solutions under appropriate lab protocols.
Metabolic research models: Suitable for receptor-binding studies, pathway mapping, and comparative analyses versus single- or dual-agonist compounds.
Technical Specifications
AttributeDetailsCAS Number2381089-83-2Molecular FormulaC₂₃₀H₃₆₀N₅₀O₆₈Molecular Weight~4,900 DaSequence (overview)39-aa peptide; includes modifications for stability and albumin bindingFormLyophilized powder (research grade)Storage–20 °C; dry, protected from light/moistureSolubilitySoluble in DMSO; aqueous buffers for working solutionsIntended UseResearch use only—not for human/veterinary use, diagnostic, or therapeutic applications
FAQ
Is this product intended for human use?
No. It is for research use only—not for human or veterinary applications.
How should it be stored?
Store lyophilized vials at –20 °C, protected from light and moisture, and follow your lab’s SOPs and the product COA.
What solvents are referenced?
References indicate solubility in DMSO; working solutions may use appropriate buffers per lab protocols.
Triple receptor agonist (GLP, GLP-1, Glucagon) for metabolic pathway research
Key Features & Research Applications
Triple receptor engagement (GLP + GLP-1 + Glucagon): Enables comprehensive investigation of incretin and glucagon pathways for glucose and energy metabolism in vitro/preclinical models.
Engineered stability: Incorporates structural modifications for extended half-life and albumin binding in research contexts
Lab-friendly format: Supplied lyophilized; recommended storage at –20 °C, protected from light/moisture; solubility references include DMSO for stock solutions under appropriate lab protocols.
Metabolic research models: Suitable for receptor-binding studies, pathway mapping, and comparative analyses versus single- or dual-agonist compounds.
Technical Specifications
AttributeDetailsCAS Number2381089-83-2Molecular FormulaC₂₃₀H₃₆₀N₅₀O₆₈Molecular Weight~4,900 DaSequence (overview)39-aa peptide; includes modifications for stability and albumin bindingFormLyophilized powder (research grade)Storage–20 °C; dry, protected from light/moistureSolubilitySoluble in DMSO; aqueous buffers for working solutionsIntended UseResearch use only—not for human/veterinary use, diagnostic, or therapeutic applications
FAQ
Is this product intended for human use?
No. It is for research use only—not for human or veterinary applications.
How should it be stored?
Store lyophilized vials at –20 °C, protected from light and moisture, and follow your lab’s SOPs and the product COA.
What solvents are referenced?
References indicate solubility in DMSO; working solutions may use appropriate buffers per lab protocols.